Bovine A-type foot-and-mouth disease multi-epitope vaccine, and preparation method and application thereof
A foot-and-mouth disease vaccine and multi-epitope technology, applied in the field of veterinary vaccine research, can solve the problems of single antigen spectrum and low immune efficacy of epitope vaccines, and achieve the effect of protection against attack and good application prospects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] The preparation of embodiment 1 bovine type A foot-and-mouth disease multi-epitope recombinant antigen
[0029] 1. Bioinformatics analysis of VP1 gene of type A foot-and-mouth disease virus:
[0030] The structural protein VP1 of foot-and-mouth disease virus is the dominant antigen of the virus. Whether it is the isolated and purified natural VP1 protein or the recombinant expression product, it can induce the body to produce protective neutralizing antibodies, which is type-specific. The VP1 gene of type A foot-and-mouth disease virus has a full length of 639 nucleotides, encoding a protein of 213 amino acids, and its dominant antigenic epitope is 140-160 amino acids and 200-213 amino acids. In this study, DNAStar biological software was used to analyze the sequences of representative strains A / WH / 09, XJKT58 and GS / LX / 62 of bovine type A foot-and-mouth disease virus recently isolated in my country, and the dominant antigenic epitope was determined to be amino acids 135...
Embodiment 2
[0036] Example 2 Preparation of Bovine Type A Foot-and-Mouth Multi-epitope Vaccine and Analysis of Immune Efficacy
[0037] 1. Vaccine preparation:
[0038] The purified protein (shown in SEQ ID NO.6) was quantified by the Bio-Rad quantitative kit and diluted to an appropriate concentration, alone or with the purified 3D protein full-length fragment (the amino acid sequence shown in SEQ ID NO.8, encoding its The nucleotide sequence is shown in SEQ ID NO.7), and the recombinant antigen was configured at 1:2 (V / V), and an equal volume of oil adjuvant ISA206 (France) was added to emulsify into a vaccine preparation.
[0039] 2. Guinea pig immune efficacy test:
[0040] Using the prepared vaccine, 0.2ml of each guinea pig was inoculated by intramuscular route (20μg antigen or 20μg antigen + 10μg 3D protein) to immunize 5 guinea pigs respectively. The results of the immunization experiment showed that no matter whether the recombinant antigen alone or combined with 3D protein immu...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com